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The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in a-linolenic acid and fibre upon dysli-
pidaemia and insulin resistance (IR), induced by intake of a sucrose-rich (62·5 %) diet (SRD). To achieve these goals two sets of experiments were
designed: (i) to study the prevention of onset of dyslipidaemia and IR in Wistar rats fed during 3 weeks with a SRD in which chia seed was the
dietary source of fat; (ii) to analyse the effectiveness of chia seed in improving or reversing the metabolic abnormalities described above. Rats were
fed a SRD during 3 months; by the end of this period, stable dyslipidaemia and IR were present in the animals. From months 3–5, half the animals
continued with the SRD and the other half were fed a SRD in which the source of fat was substituted by chia seed (SRD þ chia). The control group
received a diet in which sucrose was replaced by maize starch. The results showed that: (i) dietary chia seed prevented the onset of dyslipidaemia
and IR in the rats fed the SRD for 3 weeks – glycaemia did not change; (ii) dyslipidaemia and IR in the long-term SRD-fed rats were normalised
without changes in insulinaemia when chia seed provided the dietary fat during the last 2 months of the feeding period. Dietary chia seed reduced
the visceral adiposity present in the SRD rats. The present study provides new data regarding the beneficial effect of chia seed upon lipid and
glucose homeostasis in an experimental model of dislipidaemia and IR.
Dietary chia seed: Dyslipidaemia: Insulin resistance: Sucrose-rich diets
Numerous epidemiological and experimental studies suggest
that changes in the composition of the macronutrients of the
diet are important environmental determinants in the preven-
tion or improvement of several metabolic disorders included
in the ‘so-called’ metabolic syndrome such as type 2 diabetes,
insulin resistance, hypertension, obesity and CVD(1 – 3). In this
regard, a significant body of evidence indicates that the
dietary intake of marine PUFA (fish oil rich in 20 : 5n-3
(EPA) and 22 : 6n-3 (DHA)), involved in many biological pro-
cesses, appears to play an important role against the adverse
effects of this syndrome(2,4 – 6). On the other hand, a-linolenic
acid (ALA; 18 : 3n-3), the precursor of long-chain n-3 fatty
acids which can be converted to EPA and DHA, has received
less attention. Therefore, it is possible that dietary ALA could
exert similar physiological effects as in the case of EPA and
DHA from dietary fish oil(7). Previous results of ALA have
not always been consistent depending on the experimental
conditions such as the type and amount of oil, or feeding
period(8 – 11). Kim et al. (12) and Kim & Choi(13) reported that
in normal rats dietary perilla oil (rich in ALA) was effective
both in suppressing fatty acid synthase activity and decreasing
hepatic and plasma TAG levels compared with rats fed maize
oil rich in linoleic acid (LA; 18 : 2n-6). These effects were
associated with the increase of hepatic microsomal EPA and
DHA contents. Other studies failed to show significant diffe-
rences between LA and ALA in the hepatic lipogenesis
key enzyme activities and fatty acid synthesis(14). One of the
richest botanical sources of ALA is chia seed (Salvia
hispanica L.)(15,16). Chia, which is also rich in fibre and min-
erals, was a key component in the diet of many pre-Columbian
peoples in America, including the Mayan and the Aztec civilis-
ations. Recently Ayerza & Coates(17) demonstrated that ground
chia seed given to normal rats as a source of fat in the diet was
able to reduce plasma TAG and total cholesterol levels, and
increased HDL-cholesterol.
Several investigations have demonstrated that normal rats fed
a high-carbohydrate (particularly fructose or sucrose) diet for
3–5 weeks develop hypertriacylglycerolaemia, increased
plasma NEFA levels, hyperinsulinaemia, impaired glucose
tolerance and decreased insulin action(6,18 – 22). However, we
have shown that the metabolic and hormonal profile obtained
in rats chronically fed a sucrose-rich diet (SRD) depends
on both the length of time and the amount of sucrose
administered(23). In this regard, Chicco et al. (24,25) reported
that when the diet was extended up to 15 to 40 weeks, a steady
state of hypertriacylglycerolaemia, elevated plasma NEFA
levels, moderate hyperglycaemia, insulin resistance and altered
patterns of glucose-stimulated insulin secretion from perifused
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islets could be observed. In addition to dyslipidaemia, moderate
overweight, visceral adiposity and a substantial increase of TAG
storage in non-adipose tissues (for example, liver, pancreas,
skeletal and heart muscles) have been demonstrated(25,26).
All these metabolic effects induced by feeding a long-term SRD
closely resemble those found in humans with overweight and/or
type 2 diabetes. Interestingly, the addition of dietary fish oil to
the SRD instead of the usual oil in the rat diet for a short period
of time (2–4 weeks) was able to prevent the development of
hypertriacylglycerolaemia and the abnormal glucose homeosta-
sis(6). Moreover, earlier studies(6,26) have shown that by shifting
the source of fat in the diet (maize oil replaced by fish oil), the dys-
lipidaemia and insulin resistance induced in rats fed a long-term
(15–40 weeks) SRD are reversed. So far, only a few studies in
the literature have examined the effectiveness of dietary ALA on
the SRD-induced insulin resistance in rats. Recently,
Ghafoorunissa et al. (27) showed that in weanling rats fed a
SRD, the substitution of one-third of dietary 18 : 2n-6 with
18 : 3n-3 PUFA during 3 months resulted in lowered blood lipid
levels and partially corrected sucrose-induced insulin resistance.
Therefore, the present study investigates the possible benefits
of the dietary intake of chia seed (rich in ALA) in the prevention,
improvement and/or reversal of the dyslipidaemia and insulin
resistance induced in normal rats by feeding them a SRD.
To achieve these goals, two kinds of experiments were designed:
(i) to investigate the prevention of the development of dyslipi-
daemia and abnormal glucose homeostasis; (ii) to analyse the
effectiveness of chia seed in improving or reversing the meta-
bolic abnormalities described above. In both experimental
designs, several aspects of lipid and glucose metabolism were
studied, focusing particularly on the relationship between the
lipid-lowering actions of chia seed and the concomitant effects
on glucose homeostasis and whole-body peripheral insulin
sensitivity (euglycaemic–hyperinsulinaemic clamp).
Materials and methods
Animals
Male Wistar rats (initial weight 180–190 g; National Institute
of Pharmacology, Buenos Aires, Argentina) were maintained
with unrestricted access to water and food, under controlled
temperature (22 ^ 18C), humidity and air-flow conditions,
with a fixed 12 h light–dark cycle (light 07.00 to 19.00
hours). They were initially fed a standard laboratory chow
(Ralston Purina, St Louis, MO, USA) containing by weight
(per 100 g): 63 g starches, 3·5 g fat, 6·0 g fibre and 5 g vitamin
mixture and salt mixture. After 1 week of acclimatisation, the
rats were randomly assigned to one of the two experimental
protocols as described below. The experimental protocols
were approved by the Human and Animal Research Commi-
ttee of the School of Biochemistry, University of Litoral,
Argentina.
Dietary manipulations
Experimental design 1. Seventy-two rats were randomised
into three groups and fed an assigned diet for 3 weeks
(Table 1). The first group of rats received a semi-synthetic
diet containing maize starch (60 % energy), protein (17 %
energy) and maize oil as the source of fat (23 % energy)
(control diet). The other two groups received the same semi-
synthetic diet with sucrose as the carbohydrate and fat
provided by maize oil (SRD) or by chia seed (SRD þ chia).
Experimental design 2. Ninety-six rats were divided
into two groups and fed for 3 months with the control diet
(n 24) or SRD (n 72) previously described in Experimental
design 1. At that time, rats in the SRD groups were randomly
subdivided into three subgroups. The first subgroup was
immediately killed for each procedure as described below.
The rats in the second subgroup continued with the SRD up
to 5 months of feeding. The third subgroup received the
SRD þ chia seed as the source of dietary fat for the next
2 months. The control group was fed with the control diet
throughout the experimental period. The fibre, vitamin mix
and salt mix contents of each diet were similar. The carbo-
hydrate, protein and fibre content in the feed of the SRD þ
chia group was balanced taking into account the amount of
these nutrients present in the chia seed. The composition of
the chia seed was provided by the supplier (Table 2). The
preparation and handling of the diets have been reported
elsewhere(25). The food in the animal cages was shaded
from light and changed every day. All diets provided approxi-
mately 18·00 kJ/g chow. The weight of each animal and the
Table 1. Composition of the experimental diets*
Diet ingredients (% energy) Control diet SRD SRD þ chia seed
Carbohydrates
Starch 60 2·6 –
Sucrose – 57·4 57·4
Chia seed† – – 2·6
Fat
Maize oil 23 23 0·2
Chia seed – – 22·8
Protein
Casein (vitamin-free) 17 17 9·25
Chia seed – – 7·75
SRD, sucrose-rich diet.
* Diets are based on the AIN-93 diet. All diets contain by weight: salt mix, 3·5 %
(AIN-93M-MX(25)); vitamin mix, 1 % (AIN-93 VX(25)); choline chloride, 0·2%; meth-
ionine, 0·3 %; fibre, 12 %. The SRD þ chia was balanced in fibre and salt mix
according to the amount of each one in the chia seed provided by the manufacturer.
† Chia seed (Salba; Salvia hispanica L.): 362 g/kg diet. Chia composition (g/100 g
chia seed): carbohydrate, 37·45; insoluble fibre, 81 % of total carbohydrate; fat,
30·23; protein, 21·19. Mineral composition (mg/100 g chia seed): Na, 103·15;
K, 826·15; Ca, 589·60; Fe, 11·90; Mg, 77·0; P, 604·0; Zn, 5·32; Cu, 1·66; Mn, 1·36.
Table 2. Maize oil and chia seed fatty acid composition (g/100 total
fatty acids)
Fatty acids* Maize oil Chia seed†
16 : 0 10·40 6·60
18 : 0 2·60 2·80
18 : 1n -9 32·10 6·80
18 : 2n -6 51·50 18·60
18 : 3n -3 0·76 64·60
20 : 1n -9 0·45 0·30
Total saturated 13·40 12·04
Monounsaturated 32·55 7·44
Polyunsaturated
n -6 51·50 18·60
n -3 0·76 64·60
n -6:n -3 67·80 0·287
* Minor components made content up to 100 %.
† Salba; Salvia hispanica (Agrisalba SA, Buenos Aires, Argentina).
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energy intake were recorded twice per week during the exper-
imental period in all groups and subgroups of rats. On the day
of the experiment, food was removed at 07.00 hours (the end
of the dark period) unless otherwise indicated, and the exper-
iments were performed between 07.00 and 09.00 hours.
At least six rats from the three dietary groups were used in
each procedure. They were anaesthetised with intraperitoneal
pentobarbital Na (60 mg/kg body weight). Blood samples
were obtained from the jugular vein and rapidly centrifuged;
plasma was either immediately assayed or stored at 2208C.
The liver, skeletal muscle (gastrocnemius), epididymal and
retroperitoneal adipose tissue were totally removed, weighed
and immediately frozen and stored at the temperature of
liquid N2.
Analytical methods
Plasma TAG, NEFA, total cholesterol, HDL-cholesterol and
glucose levels were determined by spectrophotometric methods
as previously described(28). The immunoreactive insulin was
measured by the method proposed by Herbert et al. (29). The
insulin assays were calibrated against rat insulin standard
(Novo Nordisk, Bagsværd, Denmark). The TAG content was
determined in homogenates of the frozen liver and gastroc-
nemius muscle(28).
Total serum lipids were extracted according to the method
described by Folch et al. (30) in the presence of butylated
hydroxytoluene as an antioxidant. Serum fatty acids were ana-
lysed by capillary GC in a high-resolution column (60 m and
0·25 mm internal diameter) with a KNK 3000, HRGC
(Konik Instruments, Miami, FL, USA) after their derivati-
sation as methylated fatty acids(28). Fatty acids were identified
by retention time in comparison with known standards.
TAG secretion rate
The TAG secretion rate (TGSR) was evaluated in fasting rats
(16–18 h) by blocking the removal of plasma TAG with
Triton WR 1339 (600 mg/kg body weight) dissolved in 0·9 %
NaCl. The TGSR was calculated from the linear increase of
TAG v. time, following the procedure previously described by
Lombardo et al. (28).
Intravenous fat tolerance test
The intravenous fat tolerance test was performed in rats fasted
for 16–18 h by injecting intravenous Intralipidw (Intralipidw
10 % at 0·1 ml/100 g body weight), a soyabean oil fat emulsion
that has been found to be a useful tracer for the study of the
fractional turnover rate of circulating TAG(31). The disappea-
rance of Intralipidw in plasma was measured by nephelometry.
The values were plotted on a semi-logarithmic scale v. time.
The first-order rate constant (K2) of elimination of fat emul-
sion from the bloodstream (fractional removal rate) was calcu-
lated by the least-squares method as described elsewhere(28).
Euglycaemic clamp studies
Whole-body peripheral insulin sensitivity was measured using
the euglycaemic–hyperinsulinaemic clamp technique as
described elsewhere(25). Briefly, after 5 h of food deprivation,
six rats from each dietary group were anaesthetised, a blood
sample was withdrawn and glucose and insulin levels were
assessed. Afterwards, an infusion of highly purified porcine
neutral insulin (Actrapid; Novo Nordisk, Bagsværd, Denmark)
was administered at 0·8 units/(kg £ h) for 2 h. Glycaemia was
maintained at a euglycaemic level by infusing glucose (200 g/l)
at a variable rate. The glucose infusion began 5 min after the
insulin infusion started. The blood glucose concentration
was measured using a Glucomether Analyser (Boehringer
Mannheim, Indianapolis, IN, USA) within 2 min after the
samples were obtained. The glucose infusion rate during the
second hour of the clamp study was taken as the net steady
state of the whole-body glucose. In all studies, blood samples
(0·3 ml) for insulin determination(29) were obtained at 60, 90
and 120 min. Details of the methodology have been provided
elsewhere(25).
Statistical analysis
Sample sizes were calculated on the basis of measurements
previously made with rats fed either a control diet or a
SRD(20,23,25,26), considering an 80 % power. Results were
expressed as mean values with their standard errors. Statistical
comparisons were done transversely between different dietary
groups. The statistical significance between groups was deter-
mined by one-way ANOVA, with one factor (diet) followed
by the inspection of all differences between pairs of means
by the Newman–Keuls test(32). Differences having P values
lower then 0·05 were considered to be statistically significant.
In all cases the interclass correlation coefficients were at
least 0·73.
Results
Energy intake and body-weight gain
Energy intake and body weight were carefully monitored in all
groups of rats throughout both experimental periods. Fig. 1 (a)
depicts a comparable weight gain and energy intake in the rats
fed the control diet, the SRD and the SRDþ chia seed during
the first 3 weeks on the diets (Experimental design 1).
As shown in an earlier study(25), comparable weight gain
and energy intake were also recorded in the SRD and control
diet rats during the first 3 months on their respective diets
(Experimental design 2). However, a significant increase in
weight gain and energy intake was observed in the rats that
continued with the SRD up to 5 months. Even though a similar
energy intake was recorded in both the SRD and SRD þ chia
seed groups during the last 2 months of the experimental
period (3 to 5 months), the weight gain in the rats fed the
SRD þ chia seed was slightly lower than in the group of
rats fed the SRD (Fig. 1 (b)).
Fad pad and liver weights
As shown in Table 3, after 3 weeks on diet (Experimental
design 1), epididymal and retroperitoneal fat pad weight, total
or relative to 100 g body weight, were comparable in the three
dietary groups. In long-term feeding (5 months; Experimental
design 2) and in agreement with previous results(33), the epididy-
mal and retroperitoneal fat depot of the control diet-fed rats
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grew accordingly with the increase of body weight. In the SRD-
fed group, there was a significant increase in both epididymal
and retroperitoneal fat pad weights either expressed as total or
relative weight compared with the age-matched controls fed the
control diet. When chia seed replaced maize oil as the source of
dietary fat in the SRD, only a significant decrease of relative to
total weight in both fat pads was observed. In the SRD þ chia
seed group total weight of epididymal and retroperitoneal tissue
showed a slight, albeit not significant, decrease compared with
the rats fed the SRD. No differences in liver weights (total or rela-
tive to 100 g body weight) were observed in the three dietary
groups either in the short- or long-term studies (data not shown).
Plasma metabolite levels
After a 3-week feeding period (experimental design 1), both
plasma TAG and NEFA were significantly higher in the
SRD-fed rats than in the control diet-fed rats. The presence
of chia seed in the SRD group was able to prevent these altera-
tions. On the other hand, while total cholesterol was similar in
the SRD- and control diet-fed rats, there was a significant
decrease (P,0·001) in the SRD þ chia seed group (Table 4).
Moreover, the HDL-cholesterol:total cholesterol ratio was simi-
lar in the three dietary groups. Values were as follows for six rats:
61·60 (SEM 2·40) % in the control diet group, 59·50 (SEM 1·20) %
Table 3. Total and relative white adipose tissue weights of rats fed the control diet, sucrose-rich diet (SRD) or the SRD þ chia seed
(Salvia hispanica L.)
(Mean values with their standard errors for six animals per experimental group)
Epididymal weight Retroperitoneal weight
Total (g)
Relative (g/100 g
body weight) Total (g)
Relative (g /100 g
body weight)
Diet Time on diet Mean SEM Mean SEM Mean SEM Mean SEM
Experimental design 1
Control diet 3 weeks 3·38 0·22 1·20 0·04 3·20 0·34 1·21 0·09
SRD 3 weeks 3·80 0·21 1·31 0·08 3·63 0·15 1·22 0·12
SRD þ chia 3 weeks 3·45 0·15 1·19 0·02 3·15 0·14 1·09 0·08
Experimental design 2
Control diet 5 months 7·90b 0·50 1·76b 0·10 7·34b 0·80 1·67b 0·10
SRD 5 months 13·20a 1·10 2·80a 0·22 12·80a 1·00 2·50a 0·19
SRD 3 months þ
SRD þ chia 2 months 10·80a 0·85 2·10b 0·14 11·00a 0·80 1·85b 0·07
a,b Mean values in a column with unlike superscript letters were significantly different (P,0·05) when one variable at a time was compared by the
Newman–Keuls test in each experimental design.
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Fig. 1. Body weight and energy intake of rats fed a control diet (A), sucrose-rich diet (SRD; ) or the SRD þ chia seed (Salvia hispanica L.; B). Chia seed
replaced maize oil as the source of dietary fat in the SRD from the beginning of the experiment and during 3 weeks (a). Chia seed replaced maize oil as the
source of dietary fat in the SRD from 3 to 5 months of the experiment (b). Values are means for twenty-four animals per group, with standard errors represented
by vertical bars. a,b Mean values in a column with unlike superscript letters were significantly different (P,0·05) when one variable at a time was compared by the
Newman–Keuls test. * Mean value was significantly different from those of the SRD and SRD þ chia groups (P,0·05).
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in the SRD group and 66·20 (SEM 2·60) % in the SRD þ chia
seed group.
A different picture emerged after a long-term feeding period
(Experimental design 2). Plasma TAG, NEFA and total
cholesterol levels were higher either after 3 or 5 months on
the SRD than in the control diet-fed rats (P,0·01) (Table 4).
When the source of dietary fat was replaced in the SRD group
for the last 2 months on the diet (SRD þ chia seed), plasma
TAG, NEFA and total cholesterol levels reached values
similar to those of the control diet-fed animals. Furthermore,
the HDL-cholesterol:total cholesterol ratio that was signifi-
cantly decreased in the SRD-fed rats was restored to normal
values after the SRD þ chia seed. Values were as follows
for six rats: 57·3 (SEM 3·3) % in the control diet group,
32·0 (SEM 3·7) and 31·9 (SEM 2·9) % in the SRD group at
3 and 5 months, respectively, and 58·1 (SEM 3·5) % in the
SRD þ chia seed group (P,0·001 in SRD-fed rats at 3 and
5 months v. control diet- and SRD þ chia seed-fed rats).
Liver triacylglycerol, triacylglycerol secretion rate
and fractional removal rate of fat emulsion
The rats fed the SRD during 3 weeks showed a significant
increase of ‘in vivo’ TGSR and a decrease of fractional
removal rate (K2; %/min) of the intravenously injected fat
emulsion (Intralipidw) compared with the age-matched con-
trols fed the control diet (Figs. 2 (a) and (b)). This was
accompanied by a significant increase of liver TAG content
(Fig. 2 (c)). A similar picture of the above parameters was
observed after 3 or 5 months on the SRD (Figs. 2 (d), (e)
and (f)). However, the liver TAG contents in the long-term
SRD-fed rats (3 or 5 months) were significantly higher than
those recorded after 3 weeks on the SRD (Figs. 2 (c) and (f)).
The substitution of maize oil by chia seed in the SRD
(SRD þ chia seed) during 3 weeks (Experimental design 1)
significantly decreased TGSR (P,0·05) and increased the
removal rate of TAG from the circulation (P,0·05). Moreover,
liver TAG content was completely normalised (Fig. 2 (c)).
On the other hand, when chia seed replaced maize oil for
the last 2 months in the SRD (Experimental design 2), TGSR
and fractional removal rate (K2; %/min) reached values
similar to those recorded in the control diet-fed rats (Figs. 2
(d) and (e)). However, although liver TAG content significantly
decreased (P,0·05), values were still above those of the
control diet-fed group (Fig. 2 (f)).
Plasma glucose and insulin levels and glucose infusion rate
After a 3-week feeding period (Experimental design 1), plasma
glucose levels were similar in the three dietary groups. More-
over, the hyperinsulinaemia induced by the SRD previously
reported elsewhere(20,25) and confirmed in the present findings
was partially decreased in animals fed the SRD þ chia seed
(Table 5). When the SRD diet was continued up to 3 or 5
months, in both periods plasma glucose levels were greater
compared with the control diet-fed rats. However, plasma
insulin levels were similar to those observed in the control
diet group (Table 5). When the source of dietary fat was
replaced in the SRD group for the last 2 months on the diet
(SRD þ chia seed), plasma glucose returned to normal values
without any significant changes in plasma insulin levels in
all dietary groups.
To assess the effect of chia on whole-body peripheral insu-
lin sensitivity (insulin resistance), a euglycaemic–hyperinsuli-
naemic clamp study was performed at the end of both
experimental designs (1 and 2). Blood glucose was clamped
at 5·5–6·0 mM. Postprandial glucose concentration at 5 h
before the clamp was as follows for Experimental design 1
(3 weeks of feeding; six rats per group): 5·30 (SEM 0·06)
mmol/l in the control diet group, 5·50 (SEM 0·08) mmol/l in
the SRD group and 5·45 (SEM 0·05) mmol/l in the SRD þ chia
seed group. For Experimental design 2 (5 months of feeding;
six rats per group) postprandial glucose concentration at 5 h
before the clamp was: 5·28 (SEM 0·07) mmol/l in the control
diet group, 7·75 (SEM 0·12) mmol/l in the SRD group and
5·32 (SEM 0·08) mmol/l in the SRD þ chia seed group.
Postprandial glucose levels in the group of rats fed the SRD
during 3 months were similar to those recorded at 5 months
of feeding. In all dietary groups, plasma insulin levels were
similar to those obtained at the end of the dark period
in both sets of experiments (data not shown). Table 5 shows
a significant decrease of the glucose infusion rate in the
Table 4. Plasma TAG, NEFA and total cholesterol levels of rats fed the control diet, sucrose-rich diet (SRD) or the SRD þ chia
seed (Salvia hispanica L.)
(Mean values with their standard errors for six animals per experimental group)
TAG (mM) NEFA (mM)
Total cholesterol
(mM)
Diets Time on diet Mean SEM Mean SEM Mean SEM
Experimental design 1
Control diet 3 weeks 0·65b 0·04 248·3b 18·5 1·94a 0·12
SRD 3 weeks 1·45a 0·12 593·2a 24·3 1·98a 0·14
SRD þ chia 3 weeks 0·52b 0·03 239·2b 15·5 1·32b 0·11
Experimental design 2
Control diet 5 months 0·67b 0·07 300·4b 15·6 1·77b 0·15
SRD 3 months 1·79a 0·14 701·4a 42·3 3·48a 0·22
SRD 5 months 1·82a 0·12 730·7a 38·8 3·57a 0·20
SRD 3 monthsþ
SRD þ chia 2 months 0·62b 0·08 333·8b 19·1 2·20b 0·18
a,b Mean values in a column with unlike superscript letters were significantly different (P,0·05) when one variable at a time was compared by the
Newman–Keuls test in each experimental design.
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SRD-fed groups compared with the control diet-fed group,
either after 3 weeks or 3 and 5 months of feeding. However,
when chia seed replaced maize oil as the dietary fat in the
SRD, the glucose infusion rate returned to values similar to
those recorded in the control diet-fed rats in both short- and
long-term experimental feeding. There were no changes in
packed cell volume from the start to the end of the clamp
(data not shown).
Muscle TAG content
No changes in muscle TAG contents were recorded in the three
dietary groups after a 3-week feeding period (Experimental
design 1) (data not shown). However, after a long-term period
(3 or 5 months) on the SRD, the TAG content within the gastro-
cnemius muscle was significantly increased compared with
the control diet-fed group. When chia seed replaced maize
oil as the source of dietary fat in the SRD for the last 2 months
of the experimental period, the TAG content of gastrocnemius
muscle was similar to that observed in the control diet-fed rats.
Values were as follows for six rats per group: 3·08 (SEM 0·10)
mmol/g wet tissue in the control diet group, 5·06 (SEM 0·13)
mmol/g wet tissue in the SRD-fed group after 3 months,
6·97 (SEM 0·10) mmol/g wet tissue in the SRD-fed group
after 5 months and 3·10 (SEM 0·15) mmol/g wet tissue in
the SRD þ chia seed group (P,0·05; SRD after 3 months
and SRD after 5 months v. control diet or SRD þ chia
seed group).
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Fig. 2. TAG secretion rate (TGSR) (a and d), fractional removal rate of fat emulsion (K2) (b and e) and liver TAG (c and f) of rats fed a control diet (A), sucrose-
rich diet (SRD) or the SRD þ chia seed (Salvia hispanica L.). Chia seed replaced maize oil as the source of dietary fat in the SRD from the beginning of the exper-
iment and during 3 weeks (a, b and c). Chia seed replaced maize oil as the source of dietary fat in the SRD from 3 to 5 months of the experiment (d, e, f). Values
are means for six animals per group, with standard errors represented by vertical bars. ( ), SRD for 3 weeks; ( ), SRD þ chia for 3 weeks; ( ), SRD for 3 months;
( ), SRD for 5 months; ( ), SRD for 3 months then SRD þ chia for 2 months. * Mean value was significantly different from those of the control and SRD þ chia
groups (P,0·05). † Mean value was significantly different from that of the control group (P,0·05).
Table 5. Plasma glucose and insulin levels and glucose infusion rate (GIR) of rats fed the control diet, sucrose-rich diet (SRD)
or the SRD þ chia seed (Salvia hispanica L.)
(Mean values with their standard errors for six animals per experimental group)
Glucose (mM) Insulin (mU/ml)
GIR (mg glucose/kg
per min)
Diets Time on diet Mean SEM Mean SEM Mean SEM
Experimental design 1
Control diet 3 weeks 6·8 0·3 61·0b 3·9 11·0a 0·4
SRD 3 weeks 6·9 0·3 85·2a 6·1 8·9b 0·3
SRD þ chia 3 weeks 7·4 0·4 81·0a,b 9·2 11·2a 0·5
Experimental design 2
Control diet 5 months 6·9b 0·1 68·6 4·9 11·4a 0·8
SRD 3 months 8·0a 0·2 71·5 5·7 6·9b 0·9
SRD 5 months 8·1a 0·2 75·8 6·3 5·8b 0·7
SRD 3 monthsþ
SRD þ chia 2 months 7·3b 0·1 93·7 12·7 13·9a 1·1
a,b Mean values in a column with unlike superscript letters were significantly different (P,0·05) when one variable at a time was compared by the
Newman–Keuls test in each experimental design.
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Serum fatty acid analysis
Table 6 shows plasma fatty acid composition, as a percentage
of total fatty acid content, in the rats fed the control diet, SRD
or SRD þ chia seed at the end of 3 weeks of feeding. Both
palmitic (16 : 0) and stearic (18 : 0) fatty acids as well as
total SFA were similar between the dietary groups. The per-
centage of polyunsaturated n-6 LA was also similar between
the different diets while arachidonic acid (20 : 4), a metabolite
of LA, was significantly lower in the SRD þ chia seed-fed
rats. Total polyunsaturated n-6 fatty acids were significantly
lower in the SRD þ chia seed-fed group compared with the
control diet- and SRD-fed rats. When chia seed replaced
maize oil as the source of dietary fat in the rats fed the
SRD, the serum levels of the n-3 PUFA, ALA, EPA and
DHA, were significantly higher compared with those obtained
in the control diet- and SRD-fed rats. Moreover, total n-3
PUFA and the n-3:n-6 ratio were significantly higher in the
serum of the rats fed chia seed. The serum fatty acid compo-
sition at the end of the long-term feeding period (Experimental
design 2) was similar to those described above in the three
dietary groups (data not shown).
Discussion
In the present study, dietary chia seed was used instead of
maize oil (rich in LA) as the dietary source of fat to test
whether or not this nutritional intervention could prevent
and/or improve the dyslipidaemia and insulin insensitivity
induced in rats fed a SRD. The major new findings in the
present study are the following:
(1) Dietary chia seed was capable of preventing the onset of
dyslipidaemia, when it was simultaneously administered
with the SRD during 3 weeks (short-term experiment).
The addition of chia seed did not change plasma glucose
levels, and prevented the development of insulin resis-
tance. Also, the significant increase of insulinaemia
observed in the SRD-fed rats was also partially corrected.
(2) The well-established hypertriacylglycerolaemia and insu-
lin resistance resulting from a long-term (5 months) fee-
ding of normal rats with a SRD could be completely
reversed despite the fact that no changes occurred in
the circulating insulin levels when chia seed replaced
the maize oil present in the rat diet during the last
2 months of the experimental period. Moreover, dietary
chia seed decreased the visceral adiposity present in the
SRD-fed rats without any significant changes in total
body weight or energy intake.
As previously shown elsewhere(6) and now confirmed in
the present study, the substantial hypertriacylglycerolaemia
which develops in rats fed a SRD, either during 3 weeks or
5 months, is a combination of an increased hepatic VLDL-
TAG secretion and a defective removal mechanism of TAG
from the circulation.
Moreover, several studies have demonstrated that a high-
carbohydrate diet (sucrose or fructose) induces a significant
increase of liver TAG content by increased lipogenic
enzyme activities as well as by decreasing the activities of
fatty acid oxidation(6,34,35). The mechanisms involved in
these processes include the down-regulation of PPARa and
the increase of the gene expression of sterol regulatory
element-binding protein-1 (SREBP-1)(35).
It has been shown that long-chain n-3 PUFA (especially
EPA and DHA) exhibit hypolipidaemic effects by coordi-
nately suppressing hepatic lipid synthesis and secretion
while inducing hepatic and skeletal muscle fatty acid
oxidation(2,6,36). The n-3 PUFA, ALA, the major fatty acid
present in the chia seed, could be converted to long-chain
n-3 PUFA (mainly to EPA) in the liver. The effectiveness of
this bioconversion can determine its effect on plasma lipids.
Both the absolute amount of dietary ALA and the ratio of die-
tary LA:ALA influence the ALA conversion to EPA as a result
of the known competition between n-6 and n-3 fatty acids
for desaturation, since LA reduces D6 desaturase levels(37).
Jeffery et al. (38) showed that the maximum hypotriacyl-
glycerolaemic and hypocholesterolaemic effects in rats were
observed with a LA:ALA ratio of 0·33, suggesting that the
effect of ALA may be due to an increase of long-chain n-3
PUFA in membrane lipids(11,38).
The present study shows that by replacing maize oil
(LA:ALA ratio 68·2) with chia seed (LA:ALA ratio 0·287)
in rats fed a SRD during 3 weeks it was possible to prevent
the usual SRD-induced hypertriacylglycerolaemia. The mecha-
nisms involved in this process seem to be a combination of
both a significant increase of plasma TAG clearance, which
reached values higher than those recorded in the control diet
group, and a reduction of the VLDL-TGSR. Moreover, the
decreased availability of plasma NEFA could also participate,
among other mechanisms, to prevent the increase of TAG
content in the liver of the rats fed chia seed. A similar picture
emerges after a long-term SRD feeding period. In this
dietary group, hypertriacylglycerolaemia and both VLDL-
TAG secretion and plasma TAG clearance were completely
Table 6. Fatty acid composition of plasma lipids (g/100 g total fatty
acids) of rats fed the control diet, sucrose-rich diet (SRD) or the SRD þ
chia seed (Salvia hispanica L.)
(Mean values with their standard errors for six animals per experimental
group)
Control diet SRD SRD þ chia
Fatty acids* Mean SEM Mean SEM Mean SEM
16 : 0 15·90 0·32 16·35 0·50 17·80 0·58
16 : 1n -9 nd 1·02 0·04 1·05 0·07
18 : 0 10·34 0·70 11·58 0·59 10·68 0·81
18 : 1n -9 12·69 0·85 14·42 0·70 9·96 0·75
18 : 2n -6 26·88 1·95 21·48 1·80 21·02 1·59
18 : 3n -3 1·27b 0·04 0·31c 0·02 8·71a 0·67
20 : 4n -6 26·78a 1·75 29·68a 1·98 12·12b 0·98
20 : 5n -3 nd nd 6·49 0·48
22 : 4n -6 2·07a 0·17 2·20a 0·13 1·35b 0·06
22 : 5n -3 0·80b 0·07 0·19c 0·04 3·53a 0·07
22 : 6n -3 1·53b 0·04 1·76b 0·08 3·36a 0·05
Total saturated 26·24 1·97 27·93 2·01 28·48 1·48
18 : 2n -6:18 : 3n -3 21·17b 1·58 69·29a 3·90 2·41c 0·19
Total n -6 55·73a 2·30 53·36a 3·10 34·49b 3·40
Total n -3 3·60b 0·30 2·26c 0·20 22·09a 2·01
n-6:n -3 15·50b 1·01 23·61a 1·98 1·56c 0·12
nd, Not detected.
a,b,c Mean values in a column with unlike superscript letters were significantly different
(P,0·05) when one variable at a time was compared by the Newman–Keuls test.
* Minor fatty acids made content up to 100 %.
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normalised by shifting the source of fat in the diet from maize
oil to chia seed during the last 2 months of the feeding period.
Kim et al. (12) also demonstrated that the administration of
perilla oil (rich in ALA) to normal rats was effective in redu-
cing plasma and hepatic TAG levels. In spite of the twofold
decreasing plasma NEFA, the liver TAG content in the
SRD-fed rats, although significantly diminished by the
addition of chia seed, still remained high when compared
with values recorded in the control diet-fed rats. However,
the rats fed the long-term SRD showed extremely high liver
TAG content before the addition of chia seed. Under these
particular circumstances, we may assume that the time
period of chia seed intake may not have been long enough
to completely normalise the liver TAG contents. Ide(39)
demonstrated, in normal rats, that dietary ALA significantly
increased the mRNA levels of several hepatic fatty acid oxi-
dation enzymes. ALA proved to be a preferred substrate for
b oxidation and thus it was shown to reduce TAG synthesis,
decrease assembly and secretion of TAG-rich lipoprotein in
the liver, decreasing their plasma levels(40). Moreover, in the
liver the mRNA expression and enzymic activity of the lipo-
genic enzyme fatty acid synthase was inhibited in rats fed peri-
lla oil(41). Besides, the addition of chia seed decreased plasma
cholesterol levels and increased the HDL-cholesterol:choles-
terol ratio which reached values similar to those observed in
the control diet groups. In this regard, Ayerza & Coates(17)
showed a hypocholesterolaemic effect when normal rats were
fed ground chia seed during 4 weeks. Moreover, Ihara
et al. (11) showed that ALA has a more potent serum choles-
terol-lowering ability than LA. The expression of hydroxy-
methyl glutaryl CoA reductase was lower in rats fed perilla
oil than in those fed safflower-seed oil. A possible mechanism
of the action of ALA in plasma cholesterol has been suggested
to be via its conversion to EPA in the body(42). Also, the high
percentage of soluble fibre content in the whole chia seed
could also play a role in lowering plasma cholesterol levels
since the hypocholesterolaemic effect of dietary fibre in
rats(43) and other rodents(44) has been reported. Thus, both the
conversion of ALA to EPA as well as the higher soluble
fibre content in the chia seed diet could be possible mechanisms
involved in the reduction of hypercholesterolaemia in rats
fed a SRD.
Previous studies have demonstrated that diets rich in EPA
and DHA prevent excessive visceral adipose tissue growth in
rats fed either a high-fat or a high-sucrose diet(6). In the pre-
sent studies, the visceral adiposity was observed only in the
rats fed the SRD for a long term and was significantly
reduced when chia seed replaced maize oil as the source of
dietary fat. Since the food intake was similar to that of the
SRD-fed rats, this effect was unlikely to be related to
energy differences. Similarly, Okuno et al. (45) indicated a
reduction of white fat pad mass, in part by suppressing the
late phase of adipocyte differentiation in rats fed perilla oil
during 4 months compared with those fed saturated fats or
LA-rich-fat diets. However, Ghafoorunissa et al. (27) showed
in rats fed a SRD for 3 months that the substitution of
one-third of dietary LA with ALA did not reduce visceral
fat weight. Difference in the n-6:n-3 ratio present in the
diet (0·287 in the present study v. 2 in Ghafoorunissa
et al. (27)) may contribute to the effectiveness of chia seed
in improving visceral adiposity.
Confirming previous results, plasma glucose and insulin
levels evolved from normoglycaemia and hyperinsulinaemia
after a short-term (3–5 weeks) consumption of the SRD
to moderate hyperglycaemia and normoinsulinaemia after a
long-term one (from 3 up to 8 months). While in both stages
a whole-body peripheral insulin resistance was present, in the
latter period insulin sensitivity further deteriorated and it was
accompanied by a significant increase in the intramyocellular
TAG content in the skeletal muscle. In this regard, studies in
rats and human subjects have shown that the degree of insulin
resistance is strongly correlated with the local accumulation of
TAG and long-chain acyl CoA in this tissue(25,46). The adminis-
tration of chia seed prevented the development of peripheral
insulin resistance and partially decreased hyperinsulinaemia
in the rats fed the SRD during 3 weeks. Furthermore, the
impaired glucose homeostasis and peripheral insulin insensi-
tivity were completely normalised in the rats fed the SRD
during 5 months when chia seed was added for the last 2
months of the experimental period. Moreover, the TAG con-
tent within the skeletal muscle returned to normal values
after the addition of chia seed. Thus, in the present study,
the enhancement of peripheral insulin sensitivity may be
largely a result of the significant action of chia seed to
decrease circulating lipids and enhance whole-body glucose
metabolism. In this regard, long-chain n-3 PUFA, which
significantly reduce plasma lipid levels, have been shown to
prevent and/or normalise peripheral insulin resistance in
both high-sucrose- and high-fat-fed rats(6). On the other
hand, the relative and absolute amounts of LA and ALA in
the diet and the competitive interactions in the metabolism
of LA and ALA to long-chain n-6 and n-3 PUFA affect the
membrane lipid composition. This, in turn, moderates a wide
range of eicosanoid- and non-eicosanoid-mediated effects
upon the metabolic process and could directly affect insulin
action. In this regard, Ghafoorunissa et al. (27) recently demon-
strated a high level of long-chain n-3 PUFA in skeletal muscle
and adipocyte plasma membrane phospholipids in rats fed for
3 months a SRD containing a LA:ALA ratio of 2. Interest-
ingly, similar to the present results, the lipid-lowering effect
of ALA in this study was accompanied by an increase
in peripheral insulin sensitivity in both skeletal muscle and
adipose tissue. Besides, rats fed dietary perilla oil containing
neither EPA nor DHA resulted in high contents of both fatty
acids in hepatic membranes with a low content of arachidonic
acid(13). Furthermore, the present study shows an increase of
plasma long-chain n-3 PUFA levels in the rats fed the SRD
containing chia seed as compared with rats fed maize oil at
equal energy levels. Similar results were reported by Ayerza
& Coates(17) in rats fed a control diet with ground chia seed.
Thus, although in the present study we have not quantified
the fatty acid composition of skeletal muscle phospholipids,
it is possible that changes in their composition after chia
seed administration also contribute to the normalisation of
peripheral insulin resistance.
In brief, the present study provides new data regarding the
beneficial effect of chia seed (rich in ALA, fibre and minerals)
upon lipid and glucose homeostasis in our experimental
model of dyslipidaemia and insulin resistance. Caution is
warranted before extrapolating these results to humans, since
the overall efficiency of conversion of dietary ALA to EPA,
docosapentaenoic acid and DHA is very low (for a review,
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see Burdge & Calder(47)). However, Vuksan et al. (48) have
recently demonstrated that long-term supplementation with
Salba (S. hispanica L.) attenuates major (systolic blood press-
ure) and emerging cardiovascular risk factors safely beyond
conventional therapy, while maintaining good glycaemic and
lipid control in individuals with well-controlled type 2 diabetes.
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